Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in Fibromyalgia
NCT01458964Phase 4Completed
- Sponsor
- East Tennessee State University
- Start
- Jan 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in fibromyalgia (FM), sponsored by East Tennessee State University. Started Jan 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01458964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458964.